Health and Healthcare

Merck : MRK

All Merck Articles

1079 Articles

Chris Lange | Feb 10, 2016 at 9:15 AM EST

Short Sellers Increase Bets in Major Pharma

The January 29 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Jon C. Ogg | Feb 9, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce, Tesla, Yelp and More

The top analyst upgrades, downgrades and initiations seen on Tuesday include Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce,com,…

Lee Jackson | Feb 8, 2016 at 8:25 AM EST

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

If you ever want to look for value in a sector in the stock market, then when you see Congress…

Chris Lange | Feb 7, 2016 at 10:15 AM EST

How Analysts View Pfizer and Merck After Earnings

After Pfizer and Merck released their most recent earnings reports last week, analysts weighed in on both of these pharmaceutical…

Chris Lange | Feb 3, 2016 at 8:45 AM EST

Merck Trips Up Over Mixed Earnings

Merck reported mixed fourth-quarter financial results before the markets opened Wednesday.

Chris Lange | Jan 31, 2016 at 10:10 AM EST

Top 3 Dow Earnings for the Coming Week

24/7 Wall St. has put together a preview of the three Dow Jones Industrial Average companies that are reporting their…

Jon C. Ogg | Jan 30, 2016 at 10:50 AM EST

5 Dow Stocks Getting Slammed in 2016 Have Not Even Reported Earnings Yet

Some of the Dow stocks that are down in 2016 haven't even reported earnings. This is the market bracing for…

Chris Lange | Jan 28, 2016 at 8:40 AM EST

Short Sellers Become More Selective on Major Pharma

The January 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Paul Ausick | Jan 27, 2016 at 4:01 PM EST

The 4 Stocks That Tanked the Dow on Wednesday

January 27, 2016: Markets opened lower on Wednesday, but a brief morning sojourn into positive territory only lasted until the…

Jon C. Ogg | Jan 27, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Apple, AT&T, DuPont, Fitbit, Huntington Bancshares, McDonald’s, Merck, Newmont, Sprint and More

Wednesday's top analyst calls include Apple, AT&T, DuPont, Fitbit, Huntington Bancshares, McDonald's, Merck, Newmont Mining and Sprint.

Chris Lange | Jan 25, 2016 at 11:35 AM EST

Could This Merck Deal Be the Turning Point for Affimed?

Affimed shares rose on Monday following the announcement of a collaboration in immuno-oncology with biotech giant Merck.

Jon C. Ogg | Jan 20, 2016 at 7:50 AM EST

Bearish DJIA Case in 2016 Drops to 14,961 From 15,076: Chevron, Goldman Sachs, Intel, IBM, JPMorgan, Disney

Investors need to keep in mind that the downside target for the Dow Jones Industrial Average will sink lower if…

Jon C. Ogg | Jan 13, 2016 at 10:35 AM EST

The DJIA Bullish Case of 19,700 in 2016: Apple, Boeing, IBM, Nike, Pfizer, Goldman Sachs and More

A bull market interrupted is how many investors likely feel at the start of 2016. These are the seven Dow…

Chris Lange | Jan 13, 2016 at 9:15 AM EST

Major Pharma Short Sellers Increase Bets

The short interest data have been released for the December 31 settlement date. For most of the selected pharmaceutical stocks…

Lee Jackson | Jan 8, 2016 at 11:05 AM EST

Merrill Lynch Has 4 Safe Dividend-Paying Mega-Cap Pharmaceutical Stocks to Buy

One good plan for stockholders who are seeing gains evaporate is to rotate to a more defensive sector. Large cap…

1 … 37 38 39 40 41 … 72

Merck : MRK

All Merck Articles

Short Sellers Increase Bets in Major Pharma

Top Analyst Upgrades and Downgrades: Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce, Tesla, Yelp and More

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

How Analysts View Pfizer and Merck After Earnings

Merck Trips Up Over Mixed Earnings

Top 3 Dow Earnings for the Coming Week

5 Dow Stocks Getting Slammed in 2016 Have Not Even Reported Earnings Yet

Short Sellers Become More Selective on Major Pharma

The 4 Stocks That Tanked the Dow on Wednesday

Top Analyst Upgrades and Downgrades: Apple, AT&T, DuPont, Fitbit, Huntington Bancshares, McDonald’s, Merck, Newmont, Sprint and More

Could This Merck Deal Be the Turning Point for Affimed?

Bearish DJIA Case in 2016 Drops to 14,961 From 15,076: Chevron, Goldman Sachs, Intel, IBM, JPMorgan, Disney

The DJIA Bullish Case of 19,700 in 2016: Apple, Boeing, IBM, Nike, Pfizer, Goldman Sachs and More

Major Pharma Short Sellers Increase Bets

Merrill Lynch Has 4 Safe Dividend-Paying Mega-Cap Pharmaceutical Stocks to Buy

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

Merck : MRK

All Merck Articles

Short Sellers Increase Bets in Major Pharma

Top Analyst Upgrades and Downgrades: Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce, Tesla, Yelp and More

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

How Analysts View Pfizer and Merck After Earnings

Merck Trips Up Over Mixed Earnings

Top 3 Dow Earnings for the Coming Week

5 Dow Stocks Getting Slammed in 2016 Have Not Even Reported Earnings Yet

Short Sellers Become More Selective on Major Pharma

The 4 Stocks That Tanked the Dow on Wednesday

Top Analyst Upgrades and Downgrades: Apple, AT&T, DuPont, Fitbit, Huntington Bancshares, McDonald’s, Merck, Newmont, Sprint and More

Could This Merck Deal Be the Turning Point for Affimed?

Bearish DJIA Case in 2016 Drops to 14,961 From 15,076: Chevron, Goldman Sachs, Intel, IBM, JPMorgan, Disney

The DJIA Bullish Case of 19,700 in 2016: Apple, Boeing, IBM, Nike, Pfizer, Goldman Sachs and More

Major Pharma Short Sellers Increase Bets

Merrill Lynch Has 4 Safe Dividend-Paying Mega-Cap Pharmaceutical Stocks to Buy

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation